Donaldson Capital Management LLC Grows Holdings in Colgate-Palmolive (NYSE:CL)

Donaldson Capital Management LLC raised its holdings in Colgate-Palmolive (NYSE:CL) by 10.0% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 3,663 shares of the company’s stock after purchasing an additional 333 shares during the quarter. Donaldson Capital Management LLC’s holdings in Colgate-Palmolive were worth $330,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also made changes to their positions in the company. OFI Invest Asset Management purchased a new stake in shares of Colgate-Palmolive during the third quarter worth approximately $25,000. Union Savings Bank raised its position in Colgate-Palmolive by 76.6% during the 4th quarter. Union Savings Bank now owns 309 shares of the company’s stock worth $25,000 after buying an additional 134 shares during the last quarter. Avion Wealth lifted its stake in shares of Colgate-Palmolive by 78.1% in the 4th quarter. Avion Wealth now owns 399 shares of the company’s stock worth $32,000 after acquiring an additional 175 shares during the period. Atlantic Edge Private Wealth Management LLC purchased a new stake in shares of Colgate-Palmolive in the fourth quarter valued at about $32,000. Finally, Core Wealth Advisors Inc. boosted its holdings in Colgate-Palmolive by 56.6% in the 4th quarter. Core Wealth Advisors Inc. now owns 404 shares of the company’s stock valued at $32,000 after purchasing an additional 146 shares in the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.

Colgate-Palmolive Trading Up 1.9 %

NYSE CL traded up $1.72 during mid-day trading on Friday, reaching $91.01. 7,541,541 shares of the stock were exchanged, compared to its average volume of 3,968,951. The business’s fifty day simple moving average is $87.66 and its 200 day simple moving average is $81.46. The company has a debt-to-equity ratio of 8.59, a quick ratio of 0.71 and a current ratio of 1.11. The stock has a market capitalization of $74.81 billion, a PE ratio of 32.74, a PEG ratio of 3.35 and a beta of 0.42. Colgate-Palmolive has a 1-year low of $67.62 and a 1-year high of $92.25.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, April 26th. The company reported $0.86 EPS for the quarter, beating analysts’ consensus estimates of $0.82 by $0.04. Colgate-Palmolive had a return on equity of 509.75% and a net margin of 11.82%. The business had revenue of $5.07 billion during the quarter, compared to the consensus estimate of $4.96 billion. During the same quarter in the previous year, the business earned $0.73 earnings per share. The business’s revenue for the quarter was up 6.2% on a year-over-year basis. On average, research analysts anticipate that Colgate-Palmolive will post 3.5 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Monday, April 22nd will be paid a dividend of $0.50 per share. The ex-dividend date is Friday, April 19th. This represents a $2.00 dividend on an annualized basis and a yield of 2.20%. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.48. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 71.94%.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on CL shares. Morgan Stanley lifted their price target on Colgate-Palmolive from $85.00 to $93.00 and gave the company an “overweight” rating in a research note on Monday, January 29th. TheStreet raised Colgate-Palmolive from a “c+” rating to a “b+” rating in a research note on Friday, January 26th. JPMorgan Chase & Co. raised their price objective on Colgate-Palmolive from $88.00 to $90.00 and gave the company an “overweight” rating in a research note on Thursday, January 18th. Stifel Nicolaus boosted their target price on Colgate-Palmolive from $89.00 to $94.00 and gave the stock a “buy” rating in a research report on Wednesday, April 10th. Finally, Evercore ISI increased their price objective on shares of Colgate-Palmolive from $90.00 to $96.00 and gave the company an “outperform” rating in a research note on Monday, April 8th. Three equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat.com, Colgate-Palmolive has an average rating of “Moderate Buy” and an average target price of $89.50.

Insider Buying and Selling at Colgate-Palmolive

In other news, Director C Martin Harris sold 2,760 shares of the company’s stock in a transaction on Wednesday, January 31st. The stock was sold at an average price of $84.50, for a total transaction of $233,220.00. Following the completion of the sale, the director now directly owns 19,272 shares in the company, valued at approximately $1,628,484. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In related news, CEO Noel R. Wallace sold 69,948 shares of the firm’s stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $84.22, for a total value of $5,891,020.56. Following the transaction, the chief executive officer now owns 286,881 shares in the company, valued at $24,161,117.82. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director C Martin Harris sold 2,760 shares of the business’s stock in a transaction that occurred on Wednesday, January 31st. The stock was sold at an average price of $84.50, for a total transaction of $233,220.00. Following the sale, the director now owns 19,272 shares of the company’s stock, valued at $1,628,484. The disclosure for this sale can be found here. Insiders have sold a total of 232,371 shares of company stock worth $19,505,099 in the last quarter. 0.34% of the stock is owned by insiders.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.